Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare ... ( BERKELEY HEIGHTS N.J. Nov. 26 /- ...)

Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference

Date:11/26/2007

BERKELEY HEIGHTS, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced today that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide a company overview and update of corporate activities at the Lazard Capital Markets 4th Annual Healthcare Conference. Genta's presentation is scheduled for Wednesday, November 28th at 8:00 am EST at the New York Palace Hotel, New York, NY.

The presentation will be webcast and accessible at the Investor Relations section of the Company's website at: http://www.genta.com/investorrelation/events.html. The presentation will be archived for 30 days.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients for a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, which is currently undergoing initial clinical trials as a potential treatment for diseases associated with accelerated bo
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
6. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
7. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
8. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
9. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
10. Avicena Group to Present at Noble Financial Conference
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA

Post Your Comments:

(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...

(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...

(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...

(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...

[0] BioMS Medical Announces 2009 Year End Results [0] PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 [0] Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher [0] Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals

... the state will soon be able to benefit ... Manufacturing Extension Partnership (WMEP) and the University of ... will bring e-business technologies to local manufacturers. , ... chain collaboration among manufacturers and suppliers is the ...

... and CEO of Epic Systems , made a rare ... Promega BTC Center. The audience heard the CEO's perspective on ... company. , ,For over twenty years, Judy Faulkner had never ... participate on outside company boards or committees. The crowd was ...

... in Wisconsin today. Five years ago Chad Sorenson was talking ... The cousin complained about the tedious task of applying anhydrous ... his tractor and walk 40 feet behind him to determine ... was planted. , , Simple problem, high-tech solution ,Just ...

Other Biology Technology:Alliance Brings E-Business Technologies to Wisconsin Manufacturers 2 Epic's Founder Judy Faulkner Speaks on Culture, Business Beliefs, and Recruiting: WTN Exclusive Coverage 2 Epic's Founder Judy Faulkner Speaks on Culture, Business Beliefs, and Recruiting: WTN Exclusive Coverage 3 High-Tech Solution for Farmers 2

Alliance Brings E-Business Technologies to Wisconsin Manufacturers Epic's Founder Judy Faulkner Speaks on Culture, Business Beliefs, and Recruiting: WTN Exclusive Coverage High-Tech Solution for Farmers

(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...

(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...

(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...

Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2 Tryptophan-enriched diet reduces pig aggression 2 Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1 Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2 Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1 Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3

[0] Females shut down male-male sperm competition in leafcutter ants [0] Tryptophan-enriched diet reduces pig aggression [0] GenWay Biotech extends the You Test You program overseas

... construction can be significantly improved to reduce wind pressures ... winds and hurricanes in residential or commercial construction, said ... is also a civil/structural engineer, teaches at the New ... topics related to wind and earthquakes with guidelines and ...

... Spanish . Barcelona, Spain: For ... developing human embryonic stem cells (hESCs) from a single cell, ... conference of the European Society of Human Reproduction and Embryology ... from the Vrije Universiteit Brussel (VUB), Brussels, Belgium, said that ...

... bioMETRX Inc., (OTC,Bulletin Board: BMRX), today announced ... of its former competitor, Sequiam Corporation. The company ... those assets into the,company,s technology portfolio and consumer ... sold under the company,s smartTOUCH,brand., The purchase ...

Other Biology News:NJIT architect professor advocates best-building practices for high wind regions 2 Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 2 Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 3 Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 4 bioMETRX, Inc. Completes Sequiam Asset Purchase 2

NJIT architect professor advocates best-building practices for high wind regions Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns bioMETRX, Inc. Completes Sequiam Asset Purchase

Recombinant Equine IL-4, CF...

Recombinant Rat Leptin, CF...

VACUGENE PUMP 110V, 1 EA. Category: Nucleid Acid Detection Systems....

delta-like 1 homolog (Drosophila)...

Biology Products:

Equine IL-4, Unconjugated from R&D Systems Rat Leptin, Unconjugated from R&D Systems VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences Rabbit Anti-DLK1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare ...( BERKELEY HEIGHTS N.J. Nov. 26 /- ...)